Cost-Effectiveness Analysis of 1-Year Treatment with Golimumab/Standard Care and Standard Care Alone for Ulcerative Colitis in Poland

Open Access

Peer-reviewed

Research Article

Ewa Stawowczyk,

Affiliation StatSoft Polska Sp. z o.o., Krakow, Poland
⨯
Paweł Kawalec ,

* E-mail: pawel.kawalec@uj.edu.pl

Affiliation Drug Management Department, Institute of Public Health, Faculty of Health Sciences, Jagiellonian University, Krakow, Poland
⨯
Andrzej Pilc

Affiliation Department of Neurobiology, Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland
⨯

Reader Comments (0)

Ulcerative colitis
Is the Subject Area "Ulcerative colitis" applicable to this article?

Thanks for your feedback.
Surgical and invasive medical procedures
Is the Subject Area "Surgical and invasive medical procedures" applicable to this article?

Thanks for your feedback.
Corticosteroid therapy
Is the Subject Area "Corticosteroid therapy" applicable to this article?

Thanks for your feedback.
Colectomy
Is the Subject Area "Colectomy" applicable to this article?

Thanks for your feedback.
Indirect costs
Is the Subject Area "Indirect costs" applicable to this article?

Thanks for your feedback.
Cost-effectiveness analysis
Is the Subject Area "Cost-effectiveness analysis" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Drug administration
Is the Subject Area "Drug administration" applicable to this article?

Thanks for your feedback.